IDXX News and Press, IDEXX Laboratories Inc. From 02/27/23

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. The Fund increased 12.21% (Institutional Shares) during the quarter, outperforming the Russell Midcap Growth Index ...

Summary IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and consistent results that rival those of Google's, Metas', and Microsoft'...

Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity PR Newswire Major gains possible by optimizing workflow, applying technology smartly, and improving talent management WESTBROOK, Maine , Feb. 20, 2023 /PRNewswir...

Geron Corporation (NASDAQ: GERN) and Idexx Laboratories (NASDAQ: IDXX) are both poised to grow and make great long-term healthcare investments, but for different reasons. Geron, a clinical-stage biopharmaceutical company, is about to bring its first product to market, and it...

While earnings reports are a great way to monitor a stock's financial progress, checking in on a company's longer-term investment thesis is far more critical. Two examples where it would be wise to keep this theory in mind are Pinterest (NYSE: PINS) and Idexx Laboratories (NASDA...

Summary IDEXX Laboratories' share price has increased over 55% since last October. The pet healthcare company has a huge TAM and is benefiting from strong tailwinds. Its Q4 earnings were strong as margins improved once again while guidance also indicates accelerating growth. How...

IDEXX Laboratories, Inc. (IDXX) Q4 2022 Results Conference Call February 06, 2023 08:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Investor Relations Conferen...

IDEXX Laboratories press release ( NASDAQ: IDXX ): Q4 Non-GAAP EPS of $2.07 beats by $0.15 . Revenue of $828.57M (+3.4% Y/Y) beats by $7.66M . FY2023 Outlook: Revenue of $3.595B to $3.69B  and consensus of $3.62B;  operating margins of 29% to 29.6%; EPS ...

IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results PR Newswire Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 8% organic Solid growth supported by continu...